Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients

Journal of Urology

Volumn 183, Issue 5, 2010, Pages 1757-1763

  Tilki, Derya ^a,c   Reich, Oliver ^a   Svatek, Robert S ^d   Karakiewicz, Pierre I ^f   Kassouf, Wassim ^g   Novara, Giacomo ⁱ   Ficarra, Vincenzo ⁱ   Chade, Daher C ^d   Fritsche, Hans Martin ^b   Gerwens, Niklas ^a   Izawa, Jonathan I ^h   Lerner, Seth P ^e   Schoenberg, Mark ^j   Stief, Christian G ^a   Skinner, Eila ^k   Lotan, Yair ^d   Sagalowsky, Arthur I ^d   Shariat, Shahrokh F ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

carcinoma; carcinoma in situ; prognosis; survival; transitional cell; urinary bladder neoplasms

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77950520630     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.01.025     Document Type: Article

References (29)

1. van Rhijn B.W., Burger M., Lotan Y., et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 56 (2009) 430
2. Sylvester R.J., van der Meijden A.P., Witjes J.A., et al. Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174 (2005) 86
3. Huguet J., Crego M., Sabate S., et al. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 48 (2005) 53
4. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137
5. Shariat S.F., Pahlavan S., Baseman A.G., et al. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57 (2001) 60
6. Stein J.P. Indications for early cystectomy. Urology 62 (2003) 591
7. Huang G.J., Kim P.H., Skinner D.G., et al. Outcomes of patients with clinical CIS-only disease treated with radical cystectomy. World J Urol 27 (2009) 21
8. Chang S.S., Hassan J.M., Cookson M.S., et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170 (2003) 1085
9. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74
10. Hassan J.M., Cookson M.S., Smith Jr. J.A., et al. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 172 (2004) 882
11. Shariat S.F., Palapattu G.S., Amiel G.E., et al. Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology 68 (2006) 538
12. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
13. Stockle M., Alken P., Engelmann U., et al. Radical cystectomy-often too late?. Eur Urol 13 (1987) 361
14. Schrier B.P., Hollander M.P., van Rhijn B.W., et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 (2004) 292
15. Herr H.W., and Sogani P.C. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol 166 (2001) 1296
16. Witjes J.A. Bladder carcinoma in situ in 2003: state of the art. Eur Urol 45 (2004) 142
17. Lerner S.P., Tangen C.M., Sucharew H., et al. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol 27 (2009) 155
18. Shariat S.F., Kim J., Raptidis G., et al. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61 (2003) 1140
19. Shariat S.F., Kim J.H., Ayala G.E., et al. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 169 (2003) 938
20. Mitra A.P., Datar R.H., and Cote R.J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24 (2006) 5552
21. Leissner J., Koeppen C., and Wolf H.K. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 169 (2003) 955
22. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533
23. Mungan N.A., Kiemeney L.A., van Dijck J.A., et al. Gender differences in stage distribution of bladder cancer. Urology 55 (2000) 368
24. Miyamoto H., Yang Z., Chen Y.T., et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99 (2007) 558
25. Johnson E.K., Daignault S., Zhang Y., et al. Patterns of hematuria referral to urologists: does a gender disparity exist?. Urology 72 (2008) 498
26. Svatek R.S., Shariat S.F., Dinney C.P., et al. Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study. J Urol 181 (2009) 629 abstract 1744
27. Jeldres C., Isbarn H., Capitanio U., et al. Gender is an important predictor of cancer-specific survival in patient with transitional cell carcinoma after radical cystectomy. J Urol 181 suppl. (2009) 635 abstract 1761
28. Datta GD, Neville B, Datta NS et al: Gender disparities in bladder cancer survival: an assessment of socio-demographic factors. Presented at Fifth American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, abstract B38, Boston, Massachusetts, November 12-15, 2006.
29. O'Donnell M.A., and Boehle A. Treatment options for BCG failures. World J Urol 24 (2006) 481